Targeted-release budesonide modifies key pathogenic biomarkers in immunoglobulin A nephropathy: insights from the NEFIGAN trial

Autor:	Wimbury, David, Muto, Masahiro, Bhachu, Jasraj S., Scionti, Katrin, Brown, Jeremy, Molyneux, Karen, Seikrit, Claudia, Maixnerová, Dita, Pérez-Alós, Laura, Garred, Peter, Floege, Jürgen, Tesař, Vladimír, Fellstrom, Bengt, Coppo, Rosanna, Barratt, Jonathan
Zdroj:	Kidney International; 20230101, Issue: Preprints
Abstrakt:	[Display omitted]
Databáze:	Supplemental Index
Externí odkaz:	Zobrazit plný text záznamu